- Telehealth Visits
- Insurance plan information
Phuong Hoang, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
Phuong Hoang, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry/Neurology-Neurology
Residency
- Neurology, Stanford University Hospitals & Clinics GME
Internship
- Internal Medicine, Stanford University Hospitals & Clinics GME
Degree
- MDD, Columbia University, Vagelos College of Physicians & Surgeons
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224227%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224227%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 43 reviews
- February 18, 20265 out of 5 Stars
Dr. Hoang was great. She answered all of my questions and was extremely helpful. I was I lived closer so I could establish regular care with her.
- February 17, 20265 out of 5 Stars
Dr Hoang is an excellent doctor. She not only provided highly effective treatment but also delivered it carefully, minimizing pain. She also listened to my questions and provided very helpful information. I would highly recommend her to my friends and family.
- February 9, 20265 out of 5 Stars
Outstanding physician, sharp observation, and very knowledgable despite her young age.
- December 23, 20255 out of 5 Stars
Dr Hoang was very listened to me and made some changes to meds to help me
- December 16, 20255 out of 5 Stars
Knowledgeable, excellent communication. Confident in my plan of care.
- December 10, 20254.9 out of 5 Stars
This is the place to go!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.